Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research
      • Clinical Trials
    • Contact Us
    • Investors
      Careers
636.449.1830
Home > About > Overview

About Avadel Pharmaceuticals

We are a biopharmaceutical company passionately committed to providing solutions for overlooked and unmet medical needs through patient-focused, innovative products. We are thoughtful in our approach to identifying patient needs and finding better ways to serve them. Our organization fosters an entrepreneurial and determined atmosphere, where purpose, innovation, integrity and collaboration come together to provide new impactful treatment options for patients and their healthcare providers.

Our approach to developing new medicines is based on applying proprietary controlled-release technology that improves the way drugs are dosed and released. We are currently focused on the development and potential FDA approval of our lead candidate, FT218, for patients with narcolepsy.

  • LinkedIn
  • Twitter

About

  • Overview
  • Leadership
  • Board of Directors
  • Business Development
  • Corporate Responsibility

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
https://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com

© Avadel. All rights reserved.

0218 AVL WBST CMPNY_BM2

Powered by Scorpion